“Mount Sinai offers unparalleled opportunities to bring to bear basic neuroscience discoveries in order to better understand the causes of major neuropsychiatric disorders.”
Message from the Chair
Wayne K. Goodman, MD
Chair of the Department of Psychiatry
Esther and Joseph Klingenstein Professor of Psychiatry
Our Goals and Resources
The Mount Sinai Department of Psychiatry is dedicated to improving the lives of individuals suffering from mental disorders through integration of clinical care, research and teaching. The Department of Psychiatry is consistently ranked among the nation’s top twenty psychiatry departments in its level of funding from the National Institutes of Health. Likewise, in recognition of our reputation for managing the most complex and difficult cases, U.S. News & World Report ranks Mount Sinai Hospital among the top regional psychiatric services.
Mount Sinai Psychiatry is a vibrant community of clinicians, researchers, educators, and trainees dedicated to improving the welfare of individuals with mental disorders. We have 83 full-time faculty and 65 part-time faculty at our Upper East Side Campus alone. We have another 130 faculty at our affiliated sites including the Bronx VA Hospital as well as 329 voluntary faculty, many of whom are actively involved in resident supervision. We have 75 trainees in seven different residency and fellowship programs.
We pride ourselves on being a national model for translating discoveries in basic neuroscience into advances in patient care. This objective is facilitated by the organizational structure afforded by the Friedman Brain Institute in which the brain-focused clinical departments of Psychiatry, Neurology and Neurosurgery are linked with each other, and with the basic sciences via the department of Neuroscience. Our close and productive affiliation with the Bronx Veteran’s Administration Hospital, a leading center for mental health research, is another ingredient for achieving this goal. The combined resources of Mount Sinai offer unparalleled opportunities to discover new and better interventions targeting major neuropsychiatric disorders.
Progress via Psychiatric Research
Progress in advancing the treatment of major psychiatric disorders has been stymied by limits in our understanding of etiology and the virtual absence of reliable and valid biomarkers of disease. We envision a time when a psychiatric disorder can be accurately diagnosed by a combination of biomarkers and clinical indicators, leading to a selection of a personalized treatment (whether biological or behavioral) that can prevent, cure, or alter the course of, the illness – not merely ameliorate symptoms, as so many of our current treatments do. The Mount Sinai Department of Psychiatry is playing a central role in realizing this vision. Our strategy is to look beyond traditional clinical symptoms to the underlying factors that can be revealed by genetics, brain imaging or other biomarkers. Although the full payoff of this research may be years away, we are not wasting any time in bringing state-of-the-art treatment to our patients. Our trainees are taught and our patients are offered the most robust evidence-based treatments.
Our model of care calls for coupling research, clinical care and teaching in Centers of Excellence that can manage patients across the lifespan and according to acuity. We offer an array of modalities, from pharmacotherapy, to psychosocial treatments such as cognitive-behavioral therapy, to procedures such as Deep Brain Stimulation (DBS) for severe and refractory Obsessive-Compulsive Disorder (OCD). Although the thrust of our new programs has been at the ambulatory level, Mount Sinai continues to provide higher intensity care to our 103 inpatients, with specialized units for children, adolescents, the elderly, and those with , dual-diagnoses (combined substance abuse and mental disorders), in addition to general adult services. Accordingly, at a time when many psychiatric hospitals are being shuttered, we remain able to provide expert inpatient care for a wide range of conditions for patients of all ages.
Our specialty programs include:
- Mood and Anxiety Disorders
- Traumatic Stress Disorders
- Autism via the Seaver Autism Center
- Obsessive Compulsive Disorder
- Geriatric Psychiatry
- Child Psychiatry
- ADHD in children and adults
- Alzheimer’s Disease
- Brain Stimulation (ECT & DBS)
Whether you are seeking to learn about our treatment or educational programs, whether a prospective patient or trainee, we hope you will find the visit to our website informative. If you have any trouble finding what you are looking for, please feel free to e-mail me directly email@example.com and I will try to direct you to the best resource. Thank you for visiting and please think of Mount Sinai Psychiatry as your portal to the latest advances in research on, and treatment of, major mental disorders.
Icahn School of Medicine Department of Psychiatry
Mount Sinai ranks among the best in the region for Psychiatry in U.S. News & World Report’s 2013-2014 “Best Hospitals” issue. Learn more
Learn about the Department of Psychiatry's latest developments in education, research and clinical care.Read More [PDF]